Abstract:BackgroundThe use of cannabis has increased globally due to more regions decriminalizing marijuana use for therapeutic and recreational aims. Several observational studies have revealed that cannabis use is associated with an increased risk of adverse cardiovascular pathologies and diseases. Nevertheless, the causal associations between cannabis use and cardiovascular diseases remain unclear. Hence, we performed single-variable and multivariable Mendelian randomization (MR) to evaluate the association between cannabis use disorder and various cardiovascular diseases.Materials and methodsSummary statistics were collected from the largest-to-date genome-wide association studies (GWAS) of cannabis use disorder. The 12 SNPs for cannabis use disorder were used as instrumental variables in this study. MR estimates were pooled using a random-effects inverse-variance weighted (IVW) method. Simple median and weighted median methods were conducted as sensitivity analyses.ResultsThe genetic liability to cannabis use disorder was associated with an augmented risk of coronary artery disease, myocardial infarction, atrial fibrillation, heart failure, deep venous thrombosis, pulmonary embolism, and stroke. Except for stroke, the results were inconsistent in the sensitivity analyses. The overall patterns for the associations of cannabis use disorder with atrial fibrillation, heart failure, pulmonary embolism and stroke remained in multivariable MR analyses adjusting for potential mediators, including smoking, alcohol, body mass index, blood lipid, type 2 diabetes, hypertension, and depression. However, the association with coronary artery disease, myocardial infarction, and deep venous thrombosis did not persist in multivariable MR analyses. Mediation analysis demonstrated that smoking, body mass index, low-density lipoprotein, hypertension, and depression have more significant mediation effects, which suggests that these factors partly mediate the link from cannabis use disorder to coronary artery disease, myocardial infarction, and deep venous thrombosis.ConclusionThe genetic liability to cannabis use disorder was associated with a higher risk of atrial fibrillation, heart failure, pulmonary embolism, and stroke. The evidence for the association between cannabis use disorder, coronary artery disease, myocardial infarction, and deep venous thrombosis was weak. Hence, future use of cannabis for therapeutic and recreational aims should consider its potential impact on cardiovascular diseases.

Association Between Cannabis Use and Subjective Cognitive Decline: Findings from the Behavioral Risk Factor Surveillance System (BRFSS)

The association between cannabis use and subjective memory complaints in older adults in the United States

Marijuana Use and Subjective Cognitive Decline in Middle-aged and Older Adults: Analysis of the Behavioral Risk Factor Surveillance System Survey (Preprint)

The association between cannabis use and neuroimaging measures in older adults: findings from the UK biobank

Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study

Association of Cannabis Use with All-Cause and Cause-Speci Fi C Mortality among Younger- and Middle-Aged US Adults

Relationship of Cannabis Use With Immediate, Delayed, and Working Memory: The Health and Retirement Study

Cannabis Use Characteristics Associated with Self-Reported Cognitive Function in a Nationally Representative U.S. sample

Associations of cannabis use and body mass index-The Coronary Artery Risk Development in Young Adults (CARDIA) study

Associations between Cannabis Consumption Methods and Cannabis Risk Perception

Disparity between Perceptual Fall Risk and Physiological Fall Risk in Older Cannabis Users: A Pilot Study

Association of Cannabis Use Disorder with Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study

Examining Demographic Factors, Psychosocial Wellbeing and Cardiovascular Health in Subjective Cognitive Decline in the Brain Health Registry Cohort

Associations Between Simultaneous Use of Alcohol and Cannabis and Cannabis-Related Problems in 2014–2016: Evidence from the Washington Panel Survey

Association Between Cannabis Use and Brain Structures: A Mendelian Randomization Study

Age-dependent association of cannabis use with risk of psychotic disorder

Regular cannabis smoking and carotid artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)

Factors influencing patient-provider communication about subjective cognitive decline in people with COPD: Insights from a national survey

Association between cannabis use and physical activity in the United States based on legalization and health status

Unrelenting Growth and Diversification: Using the Health and Retirement Study to Illuminate Cannabis Use among Aging Americans

Cannabis use and neurocognitive performance at 13-14 Years-Old: Optimizing assessment with hair toxicology in the Adolescent brain cognitive development (ABCD) study